Literature DB >> 18988738

MTHFR 677C --> T genotype disrupts prefrontal function in schizophrenia through an interaction with COMT 158Val --> Met.

Joshua L Roffman1, Randy L Gollub, Vince D Calhoun, Thomas H Wassink, Anthony P Weiss, Beng C Ho, Tonya White, Vincent P Clark, Jill Fries, Nancy C Andreasen, Donald C Goff, Dara S Manoach.   

Abstract

Understanding how risk genes cumulatively impair brain function in schizophrenia could provide critical insights into its pathophysiology. Working memory impairment in schizophrenia has been associated with abnormal dopamine signaling in the prefrontal cortex, which is likely under complex genetic control. The catechol-O-methyltransferase (COMT) 158Val --> Met polymorphism (rs4680), which affects the availability of prefrontal dopamine signaling, consistently stratifies prefrontal activation during working memory performance. However, the low-dopamine COMT 158Val allele does not confer increased risk for schizophrenia, and its effects on prefrontal function are not specific to the disorder. In the setting of other genetic variants influencing prefrontal dopamine signaling, COMT 158Val --> Met genotype may exert disease-specific effects. A second polymorphism, methylenetetrahydrofolate reductase (MTHFR) 677C --> T (rs1801133), has been associated with overall schizophrenia risk and executive function impairment in patients, and may influence dopamine signaling through mechanisms upstream of COMT effects. We found that the hypofunctional 677T variant was associated with decreased working memory load-dependent activation in the prefrontal and insular cortices in 79 schizophrenia patients, but not in 75 demographically matched healthy controls. Further, significant MTHFR x COMT genotype interactions were observed, which differed by diagnostic group: Reduced prefrontal activation was associated with the 677T and 158Val alleles in patients, but with 677C/C and 158Met/Met genotype in controls. These findings are consistent with epistatic effects of the COMT and MTHFR polymorphisms on prefrontal dopamine signaling, and suggest that in schizophrenia patients, the MTHFR 677T allele exacerbates prefrontal dopamine deficiency. The findings also suggest the importance of weighing COMT effects on prefrontal function within the context of MTHFR genotype.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18988738      PMCID: PMC2582272          DOI: 10.1073/pnas.0803727105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Identifying regional activity associated with temporally separated components of working memory using event-related functional MRI.

Authors:  Dara S Manoach; Douglas N Greve; Kristen A Lindgren; Anders M Dale
Journal:  Neuroimage       Date:  2003-11       Impact factor: 6.556

2.  Schizophrenic subjects show aberrant fMRI activation of dorsolateral prefrontal cortex and basal ganglia during working memory performance.

Authors:  D S Manoach; R L Gollub; E S Benson; M M Searl; D C Goff; E Halpern; C B Saper; S L Rauch
Journal:  Biol Psychiatry       Date:  2000-07-15       Impact factor: 13.382

3.  Prefrontal dysfunction in schizophrenia controlling for COMT Val158Met genotype and working memory performance.

Authors:  Alessandro Bertolino; Grazia Caforio; Vittoria Petruzzella; Valeria Latorre; Valeria Rubino; Savino Dimalta; Alessandra Torraco; Giuseppe Blasi; Roberto Quartesan; Venkata S Mattay; Joseph H Callicott; Daniel R Weinberger; Tommaso Scarabino
Journal:  Psychiatry Res       Date:  2006-09-06       Impact factor: 3.222

4.  A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status.

Authors:  Simonetta Friso; Sang-Woon Choi; Domenico Girelli; Joel B Mason; Gregory G Dolnikowski; Pamela J Bagley; Oliviero Olivieri; Paul F Jacques; Irwin H Rosenberg; Roberto Corrocher; Jacob Selhub
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

5.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.

Authors:  M F Egan; T E Goldberg; B S Kolachana; J H Callicott; C M Mazzanti; R E Straub; D Goldman; D R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

6.  Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine.

Authors:  Venkata S Mattay; Terry E Goldberg; Francesco Fera; Ahmad R Hariri; Alessandro Tessitore; Michael F Egan; Bhaskar Kolachana; Joseph H Callicott; Daniel R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

Review 7.  Prefrontal cortex dysfunction during working memory performance in schizophrenia: reconciling discrepant findings.

Authors:  Dara S Manoach
Journal:  Schizophr Res       Date:  2003-04-01       Impact factor: 4.939

8.  Folate-responsive homocystinuria and "schizophrenia". A defect in methylation due to deficient 5,10-methylenetetrahydrofolate reductase activity.

Authors:  J M Freeman; J D Finkelstein; S H Mudd
Journal:  N Engl J Med       Date:  1975-03-06       Impact factor: 91.245

9.  Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer.

Authors:  Masahiro Sasaki; Masanori Kaneuchi; Noriaki Sakuragi; Rajvir Dahiya
Journal:  Cancer Res       Date:  2003-06-15       Impact factor: 12.701

Review 10.  Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond.

Authors:  Elizabeth M Tunbridge; Paul J Harrison; Daniel R Weinberger
Journal:  Biol Psychiatry       Date:  2006-02-14       Impact factor: 13.382

View more
  52 in total

1.  CNTRICS imaging biomarkers selection: Working memory.

Authors:  Deanna M Barch; Holly Moore; Derek E Nee; Dara S Manoach; Steven J Luck
Journal:  Schizophr Bull       Date:  2011-11-10       Impact factor: 9.306

2.  Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics.

Authors:  Vicki L Ellingrod; Stephan F Taylor; Gregory Dalack; Tyler B Grove; Michael J Bly; Robert D Brook; Sebastian K Zöllner; Rodica Pop-Busui
Journal:  J Clin Psychopharmacol       Date:  2012-04       Impact factor: 3.153

3.  Neuroinformatics in clinical and translational medicine--novel approaches.

Authors:  Randy L Gollub; Dennis A Turner
Journal:  Neuroinformatics       Date:  2010-12

4.  COMT Val158Met-stress interaction in psychosis: role of background psychosis risk.

Authors:  Dina Collip; Ruud van Winkel; Odette Peerbooms; Tineke Lataster; Viviane Thewissen; Marielle Lardinois; Marjan Drukker; Bart P F Rutten; Jim Van Os; Inez Myin-Germeys
Journal:  CNS Neurosci Ther       Date:  2010-11-14       Impact factor: 5.243

5.  Endothelial function, folate pharmacogenomics, and neurocognition in psychotic disorders.

Authors:  Tyler Grove; Stephan Taylor; Gregory Dalack; Vicki Ellingrod
Journal:  Schizophr Res       Date:  2015-02-23       Impact factor: 4.939

6.  Associations of cortical thickness and cognition in patients with schizophrenia and healthy controls.

Authors:  Stefan Ehrlich; Stefan Brauns; Anastasia Yendiki; Beng-Choon Ho; Vince Calhoun; S Charles Schulz; Randy L Gollub; Scott R Sponheim
Journal:  Schizophr Bull       Date:  2011-03-24       Impact factor: 9.306

7.  The COMT Val108/158Met polymorphism and medial temporal lobe volumetry in patients with schizophrenia and healthy adults.

Authors:  Stefan Ehrlich; Eric M Morrow; Joshua L Roffman; Stuart R Wallace; Melissa Naylor; H Jeremy Bockholt; Antonia Lundquist; Anastasia Yendiki; Beng-Choon Ho; Tonya White; Dara S Manoach; Vincent P Clark; Vince D Calhoun; Randy L Gollub; Daphne J Holt
Journal:  Neuroimage       Date:  2009-12-21       Impact factor: 6.556

8.  Methylenetetrahydrofolate reductase (MTHFR) polymorphism susceptibility to schizophrenia and bipolar disorder: an updated meta-analysis.

Authors:  Cai-Yun Hu; Zhen-Zhong Qian; Feng-Feng Gong; Shan-Shan Lu; Fang Feng; Yi-Le Wu; Hui-Yun Yang; Ye-Huan Sun
Journal:  J Neural Transm (Vienna)       Date:  2014-06-18       Impact factor: 3.575

9.  Perinatal folate-related exposures and risk of psychotic symptoms in the ALSPAC birth cohort.

Authors:  B Glaser; A E Ades; S Lewis; P Emmet; G Lewis; G Davey Smith; S Zammit
Journal:  Schizophr Res       Date:  2010-04-24       Impact factor: 4.939

10.  A Hybrid Machine Learning Method for Fusing fMRI and Genetic Data: Combining both Improves Classification of Schizophrenia.

Authors:  Honghui Yang; Jingyu Liu; Jing Sui; Godfrey Pearlson; Vince D Calhoun
Journal:  Front Hum Neurosci       Date:  2010-10-25       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.